VEGFR2 immunoreactivity was initially characterized in the cell line H441, a lung carcinoma-derived cell line which expresses functional VEGFR2 [38], [39], in which VEGFR2-directed siRNAs were used to manipulate VEGFR2 protein levels. Here, KDR is linked to lung carcinoma.